240 related articles for article (PubMed ID: 17711984)
1. Basal insulin, glucagon, and growth hormone replacement.
Breckenridge SM; Raju B; Arbelaez AM; Patterson BW; Cooperberg BA; Cryer PE
Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1303-10. PubMed ID: 17711984
[TBL] [Abstract][Full Text] [Related]
2. Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response.
Banarer S; McGregor VP; Cryer PE
Diabetes; 2002 Apr; 51(4):958-65. PubMed ID: 11916913
[TBL] [Abstract][Full Text] [Related]
3. Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion.
Hoelzer DR; Dalsky GP; Clutter WE; Shah SD; Holloszy JO; Cryer PE
J Clin Invest; 1986 Jan; 77(1):212-21. PubMed ID: 3511090
[TBL] [Abstract][Full Text] [Related]
4. Epinephrine's effect on metabolic rate is independent of changes in plasma insulin or glucagon.
Staten MA; Matthews DE; Cryer PE; Bier DM
Am J Physiol; 1989 Aug; 257(2 Pt 1):E185-92. PubMed ID: 2569829
[TBL] [Abstract][Full Text] [Related]
5. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
Saccà L; Sherwin R; Hendler R; Felig P
J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
[TBL] [Abstract][Full Text] [Related]
6. Role of the decrement in intraislet insulin for the glucagon response to hypoglycemia in humans.
Gosmanov NR; Szoke E; Israelian Z; Smith T; Cryer PE; Gerich JE; Meyer C
Diabetes Care; 2005 May; 28(5):1124-31. PubMed ID: 15855577
[TBL] [Abstract][Full Text] [Related]
7. Evidence against important catecholamine compensation for absent glucagon counterregulation.
De Feo P; Perriello G; Torlone E; Fanelli C; Ventura MM; Santeusanio F; Brunetti P; Gerich JE; Bolli GB
Am J Physiol; 1991 Feb; 260(2 Pt 1):E203-12. PubMed ID: 1996624
[TBL] [Abstract][Full Text] [Related]
8. Glucagon, in concert with insulin, supports the postabsorptive plasma glucose concentration in humans.
Breckenridge SM; Cooperberg BA; Arbelaez AM; Patterson BW; Cryer PE
Diabetes; 2007 Oct; 56(10):2442-8. PubMed ID: 17606872
[TBL] [Abstract][Full Text] [Related]
9. The pancreatic-adrenocortical-pituitary clamp technique for study of counterregulation in humans.
De Feo P; Perriello G; Ventura MM; Brunetti P; Santeusanio F; Gerich JE; Bolli GB
Am J Physiol; 1987 Apr; 252(4 Pt 1):E565-70. PubMed ID: 2882686
[TBL] [Abstract][Full Text] [Related]
10. GLP-1 does not not acutely affect insulin sensitivity in healthy man.
Orskov L; Holst JJ; Møller J; Orskov C; Møller N; Alberti KG; Schmitz O
Diabetologia; 1996 Oct; 39(10):1227-32. PubMed ID: 8897012
[TBL] [Abstract][Full Text] [Related]
11. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
Shilo S; Sotsky M; Shamoon H
J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
[TBL] [Abstract][Full Text] [Related]
12. Catecholamines in prevention of hypoglycemia during exercise in humans.
Marker JC; Hirsch IB; Smith LJ; Parvin CA; Holloszy JO; Cryer PE
Am J Physiol; 1991 May; 260(5 Pt 1):E705-12. PubMed ID: 1674642
[TBL] [Abstract][Full Text] [Related]
13. Decreased hepatic glucagon responses in type 1 (insulin-dependent) diabetes mellitus.
Orskov L; Alberti KG; Mengel A; Møller N; Pedersen O; Rasmussen O; Seefeldt T; Schmitz O
Diabetologia; 1991 Jul; 34(7):521-6. PubMed ID: 1916058
[TBL] [Abstract][Full Text] [Related]
14. Restoration of stable metabolic conditions during islet suppression in dogs.
Bradley DC; Bergman RN
Am J Physiol; 1992 Apr; 262(4 Pt 1):E532-8. PubMed ID: 1348903
[TBL] [Abstract][Full Text] [Related]
15. Contribution of cortisol to glucose counterregulation in humans.
De Feo P; Perriello G; Torlone E; Ventura MM; Fanelli C; Santeusanio F; Brunetti P; Gerich JE; Bolli GB
Am J Physiol; 1989 Jul; 257(1 Pt 1):E35-42. PubMed ID: 2665516
[TBL] [Abstract][Full Text] [Related]
16. Effects of insulin on the counterregulatory response to equivalent hypoglycemia in normal females.
Davis SN; Cherrington AD; Goldstein RE; Jacobs J; Price L
Am J Physiol; 1993 Nov; 265(5 Pt 1):E680-9. PubMed ID: 8238493
[TBL] [Abstract][Full Text] [Related]
17. Effect of intravenous infusion of exenatide (synthetic exendin-4) on glucose-dependent insulin secretion and counterregulation during hypoglycemia.
Degn KB; Brock B; Juhl CB; Djurhuus CB; Grubert J; Kim D; Han J; Taylor K; Fineman M; Schmitz O
Diabetes; 2004 Sep; 53(9):2397-403. PubMed ID: 15331551
[TBL] [Abstract][Full Text] [Related]
18. Effect of overnight restoration of euglycemia on glucose effectiveness in type 2 diabetes mellitus.
Basu R; Basu A; Nielsen M; Shah P; Rizza RA
J Clin Endocrinol Metab; 1999 Jul; 84(7):2314-9. PubMed ID: 10404795
[TBL] [Abstract][Full Text] [Related]
19. Primary role of glucagon release in the effect of beta-endorphin on glucose homeostasis in normal man.
Paolisso G; Giugliano D; Scheen AJ; Franchimont P; D'Onofrio F; Lefèbvre PJ
Acta Endocrinol (Copenh); 1987 Jun; 115(2):161-9. PubMed ID: 2885994
[TBL] [Abstract][Full Text] [Related]
20. Effect of somatostatin on nonesterified fatty acid levels modifies glucose homeostasis during fasting.
Hendrick GK; Frizzell RT; Cherrington AD
Am J Physiol; 1987 Oct; 253(4 Pt 1):E443-52. PubMed ID: 2889364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
